Document ID: chunk:federal_register_of_legislation:F2021L00615:reg:9:p2
Version: federal_register_of_legislation:F2021L00615
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6477–9444

is defined in the Schedule 1 - Dictionary.
(11)      ingesting food contaminated with hexachlorobenzene within the 1 year before the clinical onset of porphyria cutanea tarda;
(12)      having smoked tobacco products:
(a)          in an amount of at least 10 cigarettes per day or the equivalent thereof in other tobacco products; and
(b)          for at least the 6 months before the clinical onset of porphyria cutanea tarda; and
if smoking has ceased before the clinical onset of porphyria cutanea tarda, then that onset occurred within 30 days of cessation;
            Note: cigarettes per day or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(13)      for males, consuming a total of at least 100 kilograms of alcohol within the 10 years before the clinical worsening of porphyria cutanea tarda;
            Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(14)      for females, consuming a total of at least 50 kilograms of alcohol within the 10 years before the clinical worsening of porphyria cutanea tarda;
            Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(15)      having alcohol use disorder at the time of the clinical worsening of porphyria cutanea tarda;
(16)      having cirrhosis of the liver or steatohepatitis at the time of the clinical worsening of porphyria cutanea tarda;
(17)      having chronic renal failure at the time of the clinical worsening of porphyria cutanea tarda;
Note: chronic renal failure is defined in the Schedule 1 - Dictionary.
(18)      having hepatic iron overload at the time of the clinical worsening of porphyria cutanea tarda;
Note: iron overload is defined in the Schedule 1 - Dictionary.
(19)      having a viral infection from the specified list of viral infections at the time of the clinical worsening of porphyria cutanea tarda;
Note: specified list of viral infections is defined in the Schedule 1 - Dictionary.
(20)      taking a drug from the specified list of drugs within the 30 days before the clinical worsening of porphyria cutanea tarda;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(21)      taking a drug which is associated in the individual with:
(a)          the clinical worsening of porphyria cutanea tarda during drug therapy; and
(b)          the improvement of porphyria cutanea tarda within 2 months of discontinuing or tapering drug therapy; and
where taking the drug continued for at least the 7 days before the clinical worsening of porphyria cutanea tarda;
(22)      inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) within the 1 year before the clinical worsening of porphyria cutanea tarda;
            Note: inhaling, ingesting or having cutaneous contact with